Literature DB >> 12027715

A novel general route for the preparation of enantiopure imidazolines.

Nicola A Boland1, Mike Casey, Stephen J Hynes, Jonathan W Matthews, Martin P Smyth.   

Abstract

A novel procedure for the preparation of enantiopure 1,4-disubstituted 2-imidazolines is reported. Enantiopure beta-amino alcohols are converted into N-hydroxyethylamides, which are reacted with excess thionyl chloride, or with thionyl chloride followed by phosphorus pentachloride to yield N-chloroethylimidoyl chlorides. These intermediates are treated with amines and anilines to produce N-chloroethylamidines, which are converted into imidazolines upon workup with aqueous hydroxide. The method is simple and efficient and has been used to prepare a wide variety of enantiopure imidazolines, in a modular fashion, from readily available amino alcohols.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027715     DOI: 10.1021/jo0111006

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Palladacyclic imidazoline-naphthalene complexes: synthesis and catalytic performance in Pd(II)-catalyzed enantioselective reactions of allylic trichloroacetimidates.

Authors:  Jeffrey S Cannon; James H Frederich; Larry E Overman
Journal:  J Org Chem       Date:  2012-01-30       Impact factor: 4.354

2.  Azomethine ylide mediated inversion of configuration of quaternary imidazoline carbon: converting trans- to its cis- imidazolines.

Authors:  Ke Qu; Jason S Fisk; Jetze J Tepe
Journal:  Tetrahedron Lett       Date:  2011-09-21       Impact factor: 2.415

3.  Iridium-Catalyzed, β-Selective C(sp3)-H Silylation of Aliphatic Amines To Form Silapyrrolidines and 1,2-Amino Alcohols.

Authors:  Bo Su; Taegyo Lee; John F Hartwig
Journal:  J Am Chem Soc       Date:  2018-12-13       Impact factor: 15.419

4.  Palladium-catalyzed multicomponent synthesis of 2-imidazolines from imines and acid chlorides.

Authors:  Boran Xu; Kraig Worrall; Bruce A Arndtsen
Journal:  Molecules       Date:  2012-11-22       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.